Chief Commercial Officer
Dr. Trillo has spent over 25 years in the healthcare industry. He brings to Vyluma his clinical and commercial experience in specialty pharmaceuticals, medical devices, biologics, and healthcare provider services, along with his broad commercial experience in anesthesia, critical care, cardiology, surgery, immunology, nutrition, oncology, and hemophilia.
Prior to joining Vyluma, Dr. Trillo spent much of his career at Baxter International Inc. where he held corporate, regional, and country leadership roles in medical affairs, marketing, strategy, and general management. He also served as Chief Executive Officer of Lexington Health Network. Most recently, he was Chief Commercial Officer at Nevakar where he led the company’s portfolio strategy, business development, marketing, and commercial development efforts in both ophthalmology and hospital injectables.
Dr. Trillo received his BA and MBA from the Columbia College and Columbia Business School respectively. He earned his MD at the University of Pennsylvania, and medical internship and anesthesia training from the Hospital of the University of Pennsylvania. He obtained subspecialty training in pediatric anesthesia at the Children’s Hospital of Philadelphia.